-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported November 13, 2025: Oramed Pharmaceuticals Q3 EPS $1.26 Beats $(0.08) Estimate, Sales $2.000M

Benzinga·11/17/2025 13:58:24
Listen to the news
Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $(0.08) by 1675 percent. This is a 672.73 percent increase over losses of $(0.22) per share from the same period last year. The company reported $2.000 million in sales this quarter.